Submission of Intergrated Financials for the Half year ended September 30, 2025 approved by the Board of Directors of the Company at their meeting held on November 12, 2025

Dindigul Farm Product Limited reported its H1 FY26 (April-September 2025) standalone results. Revenue from operations rose to ₹3,828.32 lakhs from ₹3,270.17 lakhs in H1 FY25, a growth of about 17%. However, net profit fell sharply to ₹90.73 lakhs from ₹201.43 lakhs in the same period last year, a drop of roughly 55%. Total expenses grew faster than revenue, driven by a 24% jump in raw material costs and a 78% rise in depreciation (₹89.73 to ₹159.71 lakhs), likely from newly commissioned capex. EBITDA margin compressed to around 10% from about 13.3% YoY. On the positive side, operating cash flow swung to a healthy positive ₹352.46 lakhs from a negative ₹2,006.16 lakhs last year, and cash and equivalents jumped to ₹424.10 lakhs from just ₹1.68 lakhs at March-end 2025. The company also confirmed no deviation in use of IPO funds raised in June 2024 — of ₹3,163 lakhs raised, ₹2,701 lakhs has been utilised (₹750 of ₹1,212 lakhs capex, ₹1,384 lakhs working capital fully used, and ₹566.67 lakhs general corporate purpose fully used). Detailed related party transactions with holding company Indrayani Biotech, associate A R Dairy Food, director R. Rajasekaran, and his relatives were also disclosed, with total transaction value of around ₹1,357 lakhs during the period. Statutory auditor VSSR & Co. gave an unmodified review conclusion.